These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28488257)

  • 1. A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models.
    Hollman C; Paulden M; Pechlivanoglou P; McCabe C
    Pharmacoeconomics; 2017 Aug; 35(8):817-830. PubMed ID: 28488257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study.
    Hart R; Burns D; Ramaekers B; Ren S; Gladwell D; Sullivan W; Davison N; Saunders O; Sly I; Cain T; Lee D
    Pharmacoeconomics; 2020 Jul; 38(7):765-776. PubMed ID: 32236891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.
    Incerti D; Thom H; Baio G; Jansen JP
    Value Health; 2019 May; 22(5):575-579. PubMed ID: 31104737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing three software tools for implementing markov models for health economic evaluations.
    Menn P; Holle R
    Pharmacoeconomics; 2009; 27(9):745-53. PubMed ID: 19757868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.
    Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2017 Jul; 35(7):673-683. PubMed ID: 28456972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code.
    Möller J; Davis S; Stevenson M; Caro JJ
    Pharmacoeconomics; 2017 Oct; 35(10):1103-1109. PubMed ID: 28669122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discrete-event simulation models in the economic evaluation of health technologies and health products].
    Rodríguez Barrios JM; Serrano D; Monleón T; Caro J
    Gac Sanit; 2008; 22(2):151-61. PubMed ID: 18420015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to Cost Analysis in IR: Challenges and Opportunities.
    Roudsari B; McWilliams J; Bresnahan B; Padia SA
    J Vasc Interv Radiol; 2016 Apr; 27(4):539-545.e1. PubMed ID: 26922978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision analysis and economic modelling: a primer.
    Inadomi JM
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):535-42. PubMed ID: 15167154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of R in Health Decision Sciences.
    Jalal H; Pechlivanoglou P; Krijkamp E; Alarid-Escudero F; Enns E; Hunink MGM
    Med Decis Making; 2017 Oct; 37(7):735-746. PubMed ID: 28061043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An introduction to the methods of decision-analytic modelling used in economic evaluations for Dermatologists.
    McManus E; Sach TH; Levell NJ
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1829-1836. PubMed ID: 31127965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
    Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
    Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
    Schmitz S; McCullagh L; Adams R; Barry M; Walsh C
    Pharmacoeconomics; 2016 Sep; 34(9):925-37. PubMed ID: 27034245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.
    Krijkamp EM; Alarid-Escudero F; Enns EA; Jalal HJ; Hunink MGM; Pechlivanoglou P
    Med Decis Making; 2018 Apr; 38(3):400-422. PubMed ID: 29587047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primer on medical decision analysis: Part 5--Working with Markov processes.
    Naimark D; Krahn MD; Naglie G; Redelmeier DA; Detsky AS
    Med Decis Making; 1997; 17(2):152-9. PubMed ID: 9107610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.